SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma

Huayi Feng(Chinese PLA General Hospital), Xu Zhang(Chinese PLA General Hospital)
Discover Oncology
December 7, 2022
Cited by 18


Related Papers